返回
Poniard Pharmaceuticals Inc（PARD）價格
PARD 股價走勢圖
PARD 收益
Poniard Pharmaceuticals Inc
$0
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$0
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.0001
開盤價
$0.0001
當日範圍
$0.0001 - $0.0001
52週區間
$0.0001 - $0.0001
交易量
7
平均成交量
162
每股盈餘 (TTM)
-11.78
股息收益率
--
市值
$150
什麼是 PARD？
Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
